2023 events
-
Understanding and Improving Bacterial Cancer Therapy: from stem cell invasion to T cell dysfunction
Join us as Dr Kendle Maslowski discusses the potential of bacterial cancer therapy.
-
Genetic manipulation of stem cell derived red blood cells
Dr Tim Satchwell (School of Biochemistry - University of Bristol) presents his research.
-
Saving your bacon: Tackling the other global outbreak
Dr Amanda Warr joins us from the Roslin Institute, Edinburgh, for this seminar.
-
Defining genetic and environmental determinants of malaria transmission
Professor Matthias Marti will present and discuss data demonstrating that both environmental and genetic factors contribute to the regulation of malaria transmission.
-
Biochemical control of cellular decision making
Dr Tony Ly (School of Life Sciences - University of Dundee) presents this seminar, discussing the work of his research group in understanding how cyclin-dependent kinase (CDK1) substrate phosphorylation is ordered during cell cycle progression.
-
Glioblastoma response to standard treatment stratifies patients into two responder subtypes, creating the potential for precision medicine
Dr Lucy Stead, Associate Professor, Leeds Institute of Medical Research at St James's, joins us for this seminar
-
Invasion and Adaptation: Exploring Trypanosoma brucei's Phenotypic Flexibility in Host Tissues
Dr Luisa Miranda Figueiredo (Instituto de Medicina Molecular (IMM), University of Lisbon) discuss the phenotypic adaptation of T. brucei parasites to adipose tissue and the initial progress in understanding tissue-specific invasion mechanisms.
-
Use of the cytoskeleton to control Shigella infection
Dr Serge Mostowy joins us from the London School of Health and Tropical Medicine for this seminar.
-
Targeting cell cycle and transcriptional dependencies in estrogen receptor positive breast cancer by inhibition of cyclin-dependent kinase CDK7
Professor Simak Ali discusses the role estrogen plays in the development of breast cancer and how CDK7 could be used to inhibit the process.
-
Establishing Computational Microbiology: with a Focus on Cell Envelopes
Details to be confirmed.
-
Targeting b-catenin in acute myeloid leukaemia
Dr Rhys Morgan will be joining us for an engaging seminar.
-
Image-based drug screening in patient biopsies for personalized systems medicine and drug discovery
Professor Dr Berend Snijder joins us for this seminar discussing their work in the Snijder Lab developing Pharmacoscopy to tackle the challenge of identifying effective cancer treatments for individual patients.
-
Rescuing mitochondria in peril under oxidative stress
Mitochondria have defence mechanisms to respond to stresses, Professor Kostas Tokatlidis discusses these processes in further detail.
-
Genetic tools for Cryptosporidium biology and drug discovery
Dr Mattie Pawlowic of the School of Life Sciences, University of Dundee, joins us for this seminar.
-
Biological timing, homeostasis and infectious disease
Dr Rachel Edgar from Imperial College London joins us for this talk.
-
Developmental origins of blood stem cells and leukaemia
My lab has a long-standing interest in how the first blood cells, particularly haematopoietic stem cells, are generated during development and how they differ from adult blood cells.
-
Re-programming by the YAP1 and TAZ transcription factors is essential for virus-driven transformation and stratification in cervical cancer
Professor Andrew Macdonald, Chair of Tumour Virology at the University of Leeds, joins us for this seminar discussing virus-driven transformation and stratification in cervical cancer.
-
Have it my way! How intracellular parasites remodel your cells to their needs
This event has been cancelled.
-
How the cancer associated stroma changes with disease progression
Dr Damien Leach of Imperial College London joins us for this seminar discussing the changes and progression of cancer associated stroma
-
AML vs T cells, what tilts the balance – and can we tamper the scale to achieve cure?
Dr Constandina Pospori joins us from Imperial College, London to present her recent work proposing that the dynamic regulation of hierarchical heterogeneity in AML can serve as a tumour immunoevasion mechanism and facilitate disease progression.